文献速递消化内镜消化道肿瘤与早癌

一种新型计算机辅助检测系统对结直肠肿瘤的价值:一项随机对照试验

Usefulness of a novel computer-aided detection system for colorectal neoplasia: a randomized controlled trial.
PubMed 文献 · Gastrointest Endosc · 2022-10-11

这项随机对照试验纳入370例连续患者,1:1随机分为ENDO-AID(OIP-1)计算机辅助检测组(n=185)与标准结肠镜检查组(n=185),主要终点为腺瘤检出率(ADR)。意向性分析显示,CADe组ADR为55.1%(102/185),对照组为43.8%(81/185),差异有统计学意义(P=.029);CADe组非进展期ADR、平坦型ADR、息肉检出率及每结肠镜腺瘤数均显著高于对照组。

要点

  • CADe组ADR为55.1%(102/185),对照组为43.8%(81/185),差异有统计学意义(P=.029)。
  • CADe组非进展期ADR为54.8%,对照组为40.8%(P=.01);平坦型ADR分别为39.4%与24.8%(P=.006)。
  • 按内镜医师ADR和肠道清洁度分层后,两组ADR未见统计学显著差异。

核心结论

  • ENDO-AID(OIP-1)辅助结肠镜可提高ADR和每结肠镜腺瘤数,提示其可能有助于检出结直肠肿瘤性病变,尤其是微小腺瘤和平坦腺瘤。

研究设计与样本

  • 随机对照试验,纳入370例连续患者,1:1随机分为CADe组(n=185)与标准检查组(n=185),研究时间为2021年11月至2022年1月。
  • 主要终点为ADR;进展期腺瘤定义为≥10 mm、伴高级别上皮内瘤变或绒毛状结构,否则为非进展期腺瘤。
  • ADR按内镜医师ADR和肠道清洁度分层评估。

主要发现

  • 意向性分析中,CADe组ADR为55.1%(102/185),对照组为43.8%(81/185),差异有统计学意义(P=.029)。
  • CADe组非进展期ADR为54.8%,对照组为40.8%(P=.01)。
  • CADe组平坦型ADR为39.4%,对照组为24.8%(P=.006)。
  • CADe组息肉检出率为67.1%,对照组为51%(P=.004)。
  • CADe组每结肠镜腺瘤数中位数为1(第25-75百分位0-2),对照组为0(第25-75百分位0-1.5),差异有统计学意义(P=.014);两组锯齿状ADR未见显著差异。

临床怎么用

  • 原文结论认为ENDO-AID(OIP-1)辅助结肠镜可提高ADR和每结肠镜腺瘤数,可能有助于检出结直肠肿瘤性病变。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Artificial intelligence-based computer-aid detection (CADe) devices have been recently tested in colonoscopies, increasing the adenoma detection rate (ADR), mainly in Asian populations. However, evidence for the benefit of these devices in the occidental population is still low. We tested a new CADe device, namely, ENDO-AID (OIP-1) (Olympus, Tokyo, Japan), in clinical practice. METHODS: This randomized controlled trial included 370 consecutive patients who were randomized 1:1 to CADe (n = 185) versus standard exploration (n = 185) from November 2021 to January 2022. The primary endpoint was the ADR. Advanced adenoma was defined as ≥10 mm, harboring high-grade dysplasia, or with a villous pattern. Otherwise, the adenoma was nonadvanced. ADR was assessed in both groups stratified by endoscopist ADR and colon cleansing. RESULTS: In the intention-to-treat analysis, the ADR was 55.1% (102/185) in the CADe group and 43.8% (81/185) in the control group (P = .029). Nonadvanced ADRs (54.8% vs 40.8%, P = .01) and flat ADRs (39.4 vs 24.8, P = .006), polyp detection rate (67.1% vs 51%; P = .004), and number of adenomas per colonoscopy were significantly higher in the CADe group than in the control group (median [25th-75th percentile], 1 [0-2] vs 0 [0-1.5], respectively; P = .014). No significant differences were found in serrated ADR. After stratification by endoscopist and bowel cleansing, no statistically significant differences in ADR were found. CONCLUSIONS: Colonoscopy assisted by ENDO-AID (OIP-1) increases ADR and number of adenomas per colonoscopy, suggesting it may aid in the detection of colorectal neoplastic lesions, especially because of its detection of diminutive and flat adenomas. (Clinical trial registration number: NCT04945044.).

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Gimeno-García AZ, Hernández Negrin D, Hernández A, et al. Usefulness of a novel computer-aided detection system for colorectal neoplasia: a randomized controlled trial. Gastrointest Endosc. 2022. PMID: 36228695. doi:10.1016/j.gie.2022.09.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。